Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

IMA901 in Advanced Renal Cell Carcinoma Patients With Measurable Disease (IMA901-202)

This study has been completed.
Information provided by (Responsible Party):
immatics Biotechnologies GmbH Identifier:
First received: August 30, 2007
Last updated: July 9, 2012
Last verified: February 2010
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2009
  Primary Completion Date: August 2009 (Final data collection date for primary outcome measure)